WeVote

Bill

Bill

SSB 1207

A bill for an act relating to pharmacy benefits managers, pharmacies, and prescription drugs.

2025-2026 Regular Session

Iowa bill regulates pharmacy benefits managers and prescription drug practices to address cost transparency and pharmacy operations in state insurance markets.

Subcommittee recommends amendment and passage.
0
WeVote Research Nonpartisan
Bill Summary · SSB 1207

Legislative bill overview

SSB 1207 addresses regulations governing pharmacy benefits managers (PBMs), pharmacies, and prescription drug operations in Iowa. The bill was recently introduced and referred to the Commerce Committee, with a subcommittee already recommending amendments and passage after its March 6 hearing.

Why is this important

PBMs act as intermediaries between insurers, pharmacies, and patients, significantly influencing drug prices and pharmacy operations. How Iowa regulates these entities directly affects prescription drug costs, pharmacy profitability, patient access to medications, and insurance premiums for state residents.

Potential points of contention

  • PBM transparency requirements: Proposals to mandate cost disclosures could conflict with PBM competitive interests and proprietary business practices
  • Pharmacy reimbursement rates: Any provisions regulating how much PBMs reimburse pharmacies may face opposition from PBM industry groups concerned about reduced margins
  • Patient access vs. cost control: Balancing affordability measures with maintaining robust pharmacy networks and drug availability could create tension between consumer advocates and industry stakeholders

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.